Literature DB >> 9037524

Altered expression of group I metabotropic glutamate receptors in the hippocampus of amygdala-kindled rats.

M T Akbar1, M Rattray, J F Powell, B S Meldrum.   

Abstract

Kindling is a well documented model of acquired focal epilepsy and synaptic plasticity in the nervous system. Previous biochemical studies have indicated an increase in mGluR-mediated phosphoinositide hydrolysis in the amygdala or hippocampus of fully kindled animals. In this study we have used in situ hybridisation techniques to examine the mRNA expression of group I metabotropic glutamate receptors (mGluR1 and mGluR5 both linked to phosphoinositide hydrolysis) in the hippocampus of amygdala-kindled animals sacrificed 24 h, 7 days or 28 days following the last electrically evoked stage 5 seizure, and in implanted non-stimulated control rats. Results indicate an initial up-regulation in mGluR1 mRNA (expressed as percentage of control) bilaterally in the DG (35-40%) and CA3 (16-48%), and unilaterally in CA4 (12%) in the 24 h post-kindled group. In kindled animals studied 7 days after the last seizure, these changes were either reduced or had returned to control levels. By 28 days mGluR1 mRNA levels had returned to control levels, with only a persistent increase in expression unilaterally in the DG (14%). In contrast, an initial down-regulation in mGluR5 mRNA was observed bilaterally in CA4 (-45 and -25%) and CA1 (-46 and -45%), and unilaterally in DG and CA3 (-27 and -42% respectively) 24 h after the last kindled seizure. In the 7 and 28 day kindled groups significant alterations in expression of mGluR5 mRNA were still apparent. These data show that the mRNAs for mGluR1 and mGluR5 are differentially regulated by kindling, indicating that the expression of each of these receptors is under independent regulatory control. These perturbations in mRNA expression may contribute to kindling epileptogenesis but are unlikely to account for the maintenance of the kindled state.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9037524     DOI: 10.1016/s0169-328x(96)00162-3

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

1.  Group I mGluR-induced epileptogenesis: distinct and overlapping roles of mGluR1 and mGluR5 and implications for antiepileptic drug design.

Authors:  Robert K S Wong; Riccardo Bianchi; Shih-Chieh Chuang; Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2005 Mar-Apr       Impact factor: 7.500

2.  The ups and downs of hippocampal metabotropic glutamate receptors: ramifications for epileptogenesis and cognitive impairment following status epilepticus.

Authors:  Lisa R Merlin
Journal:  Epilepsy Curr       Date:  2008 Mar-Apr       Impact factor: 7.500

3.  RGS4 inhibits signaling by group I metabotropic glutamate receptors.

Authors:  J A Saugstad; M J Marino; J A Folk; J R Hepler; P J Conn
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

Review 4.  The role of glutamate and its receptors in the proliferation, migration, differentiation and survival of neural progenitor cells.

Authors:  Linda C Jansson; Karl E Åkerman
Journal:  J Neural Transm (Vienna)       Date:  2014-02-23       Impact factor: 3.575

5.  Differential binding of calmodulin to group I metabotropic glutamate receptors regulates receptor trafficking and signaling.

Authors:  Kyu Yeong Choi; Seungsoo Chung; Katherine W Roche
Journal:  J Neurosci       Date:  2011-04-20       Impact factor: 6.167

6.  Transcriptomic profiling of nonneoplastic cortical tissues reveals epileptogenic mechanisms in dysembryoplastic neuroepithelial tumors.

Authors:  Krishan Kumar; Aparna Banerjee Dixit; Manjari Tripathi; Vivek Dubey; Fouzia Siraj; Mehar Chand Sharma; Sanjeev Lalwani; P Sarat Chandra; Jyotirmoy Banerjee
Journal:  Funct Integr Genomics       Date:  2022-05-28       Impact factor: 3.674

7.  Agonists and antagonists of metabotropic glutamate receptors: anticonvulsants and antiepileptogenic agents?

Authors:  Feng Ru Tang
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

Review 8.  Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders?

Authors:  Maria Vincenza Catania; Simona D'Antoni; Carmela Maria Bonaccorso; Eleonora Aronica; Mark F Bear; Ferdinando Nicoletti
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

9.  Rapid loss of efficacy to the antiseizure drugs lamotrigine and carbamazepine: a novel experimental model of pharmacoresistant epilepsy.

Authors:  Ajay K Srivastava; Anitha B Alex; Karen S Wilcox; H Steve White
Journal:  Epilepsia       Date:  2013-06-10       Impact factor: 5.864

10.  Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis.

Authors:  Ludmyla Kandratavicius; Pedro Rosa-Neto; Mariana Raquel Monteiro; Marie-Christine Guiot; Joao Alberto Assirati; Carlos Gilberto Carlotti; Eliane Kobayashi; Joao Pereira Leite
Journal:  Hippocampus       Date:  2013-07-23       Impact factor: 3.899

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.